William M. Burns

William “Bill” Burns is the Chairman of Molecular Partners. Bill Burns worked for Roche in various positions for 28 years culminating in the position as CEO of Roche Pharmaceuticals (2001-2009) ….

MORE

Dr. Göran Ando

Dr. Göran Ando is the Vice-Chairman of Molecular Partners. He is the retired Chairman of the board of directors of Novo Nordisk A/S. He was CEO of Celltech Group plc, UK, until 2004. Dr. Ando joined Celltech from Pharmacia …

MORE

Steven H. Holtzman

Steven H. Holtzman joined Decibel Therapeutics as president and chief executive officer in 2016. Decibel discovers and develops novel therapeutic approaches to treat hearing loss and other hearing disorders …

MORE

Dr. William A. Lee

Dr. William “Bill” Lee is Executive Vice President Research at Gilead Sciences. Dr. Lee joined Gilead as Director of Pharmaceutical Product Development in 1991. Prior to joining Gilead, he was Department Head …

MORE

Dr. Petri Vainio

Petri Vainio, MD, PhD. has spent his entire career as an investor and board member in rapidly growing healthcare companies. He has been a lead investor in numerous successful healthcare companies …

MORE

Dr. Gwen Fyfe

Dr. Gwen Fyfe has more than 20 years of drug development experience in oncology. She held various positions at Genentech from 1997-2009, including vice president, oncology development …

MORE

Dr. Patrick Amstutz

Dr. Patrick Amstutz has been Chief Executive Officer of Molecular Partners since November 2016. From 2014 to 2016, he was Chief Operating Officer and from 2006 to 2014, Chief Business Officer …

MORE

 

 

Audit and Finance Committee

Nomination and Compensation Committee

Science Committee         

Dr. Petri Vainio (Chairperson)

William M. Burns (Chairperson)

Dr. William A. Lee (Chairperson)

William M. Burns

Dr. William A. Lee

Dr. Gwen Fyfe

Steven Holtzman

Dr. Göran Ando